Beverly Capital Invests in The Eye Health Group as it Continues Northeast Expansion

By
LOS ANGELES—Beverly Capital, a Los Angeles-based private equity firm, has acquired The Eye Health Group, a New Jersey-based medical optometric service provider. The Eye Health Group is a leading vision support organization that assists its nine New Jersey and New York practice providers in performing comprehensive eyecare services. The Eye Health Group practices are located within Pearle Vision locations. The Eye Health Group’s management team will remain involved in the operations of the business, according to the announcement Wednesday.

The Eye Health Group provides a full suite of medical eyecare services, from diagnosis and management of eye diseases to pathology, lab testing and pre- and post-operative care for surgical patients, as well as prescribing and dispensing contact lenses and vision corrective glasses.

“At Beverly Capital, we focus on bringing growth capital and operational excellence to the companies in which we invest,” Daniel Rudyak, managing director at Beverly Capital, said in the announcement. “We see an opportunity to build upon this platform investment with additional acquisitions of eye health practices along the East Coast. We look forward to working with The Eye Health Group to help it scale, innovate and continue to succeed in the years ahead.”

The Eye Health Group chief executive officer Dr. Randy Nissinoff said he believes the Covid pandemic has accelerated change in the optometry sector.

“A patient-centric model, robust medical offerings, and large regional footprint will be needed to thrive in the future,” he added. “We are proud of the tremendous care and compassion provided by the significantly growing number of optometric doctors that The Eye Health Group supports, and are excited about our new partnership with Beverly Capital, providing us an ability to expedite our growth across the Northeast.”

Everside Capital Partners, a New York-based investment firm, and Merion Investment Partners, a Radnor, Pa.-based investment firm, joined Beverly Capital in the investment.